Evidence map›Paper›PMID 29805297›Full record

ArticleEuropean journal of organic chemistry2018

Pre-activation Based Stereoselective Glycosylations.

Bo Yang, Weizhun Yang, Sherif Ramadan, Xuefei Huang

Abstract read
In one paragraph

Article in European journal of organic chemistry, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Recent Advances in Stereoselective ChemicalFrontiers in molecular biosciences · 2022
    Review
  6. Ferrocenium complex aidedRSC advances · 2021
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Bo YangDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, MI 48824 USA.
Weizhun YangDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, MI 48824 USA.
Sherif RamadanDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, MI 48824 USA.
Xuefei HuangDepartment of Chemistry, Michigan State University, 578 South Shaw Lane, East Lansing, MI 48824 USA.

Funding

Homogeneous Heparan Sulfate Glycopeptides: Synthetic and Functional StudiesR01GM072667 · NIGMS · UNIVERSITY OF TOLEDO · PI HUANG, XUEFEI · 2005 to 2024
$5.1M
NIGMS NIH HHS R01 GM072667
6 · The paper itself

Abstract

Due to the wide presence of carbohydrates in nature and their crucial roles in numerous important biological processes, oligosaccharides have attracted a lot of attention in synthetic organic chemistry community. Many innovative synthetic methods have been developed for oligosaccharide synthesis, among which the pre-activation based glycosylation is particularly noteworthy. Traditionally, glycosylation reactions are carried out when the glycosyl donor and the acceptor are both present when the promoter is added. In comparison, the pre-activation based glycosylation is unique, where the glycosyl donor is activated by the promoter in the absence of the acceptor. Upon complete donor activation, the acceptor is added to the reaction mixture enabling glycosylation. The key step in any oligosaccharide synthesis is the stereoselective formation of the glycosidic bond. As donor activation and acceptor glycosylation are temporally separated, pre-activation based glycosylation can bestow unique stereochemical control. This review systematically discusses factors impacting the stereochemical outcome of a pre-activation based glycosylation reaction including substituents on the glycosyl donor, reaction solvent, and additives. Applications of pre-activation based stereoselective glycosylation in assembly of complex oligosaccharides are also discussed.

Indexed as

diastereoselectivityglycosidesglycosylationpre-activationsynthesis design

Identifiers

PMID29805297
PMCPMC5963711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.